“That is why I trust”: a qualitative study on acceptability and feasibility of novel tongue swab diagnostics to assess people presenting with tuberculosis symptoms in Viet Nam and Zambia
Alyssa Sales(University of California, San Francisco), Monde Muyoyeta(Centre for Infectious Disease Research in Zambia), Evelyn Muleba Kunda‐Ng'andu, Nora West(University of California, San Francisco), Ha Phan(Center for Promotion of Advancement of Society), Seke Muzazu(Centre for Infectious Disease Research in Zambia), Andrew D. Kerkhoff(San Francisco General Hospital), Adithya Cattamanchi(University of California, San Francisco), María del Mar Castro(Centro Internacional de Entrenamiento e Investigaciones Medicas), Hien Thi Thu Le(University of California, San Francisco), Claudia M. Denkinger(Heidelberg University)
Cited by 5
Related Papers
Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis
|Clinical Infectious Diseases|2016|1.5k
Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study
|The Lancet Infectious Diseases|2017|688
Xpert MTB/RIF assay for the diagnosis of extrapulmonary tuberculosis: a systematic review and meta-analysis
|European Respiratory Journal|2014|532